Cholecystitis resident survival guide: Difference between revisions
No edit summary |
|||
Line 47: | Line 47: | ||
:❑ RUQ pain with fever & jaundice</div></div><br>❑ Pain associated with Sx suggestive of gallstone ileus<div class="mw-collapsible-content"> <div class="mw-collapsible mw-collapsed"> | :❑ RUQ pain with fever & jaundice</div></div><br>❑ Pain associated with Sx suggestive of gallstone ileus<div class="mw-collapsible-content"> <div class="mw-collapsible mw-collapsed"> | ||
:❑ Transient abdominal pain with nausea & vomiting | :❑ Transient abdominal pain with nausea & vomiting | ||
:❑ Hematemesis</div></div></div>|B02=<div style="float: left; text-align: left; line-height: 150% ">❑ Acute vague abdominal pain<br>❑ RUQ mass<br>❑ Jaundice<br>❑ Fever</div>|B03=<div style="float: left; text-align: left; line-height: 150% ">❑ Recurrent biliary type abdominal pain<br>❑ Recurrent abdominal bloating<br>❑ Unstable stool with constipation/diarrhea<br>❑ Weight loss</div>|B04=<div style="float: left; text-align: left; line-height: 150% ">[[Cholecystitis ultrasound#Chronic Calculous and Acalculous Cholecystitis|TAUSG]]<BR>[[Cholecystitis CT#Chronic Calculous and Acalculous Cholecystitis|CT abdomen]]<br>[[Cholecystitis other diagnostic studies#Chronic Cholecystitis|HIDA scan]]<br>[[Cholecystitis other diagnostic studies#Chronic Cholecystitis|Cholecystokinin stimulated HIDA scan]]</div>}} | :❑ Hematemesis</div></div></div>|B02=<div style="float: left; text-align: left; line-height: 150% ">❑ Acute vague abdominal pain<br>❑ RUQ mass<br>❑ Jaundice<br>❑ Fever</div>|B03=<div style="float: left; text-align: left; line-height: 150% ">❑ Recurrent biliary type abdominal pain<br>❑ Recurrent abdominal bloating<br>❑ Unstable stool with constipation/diarrhea<br>❑ Weight loss</div>|B04=<div style="float: left; text-align: left; line-height: 150% ">'''Imaging studies:'''<br>[[Cholecystitis ultrasound#Chronic Calculous and Acalculous Cholecystitis|TAUSG]]<BR>[[Cholecystitis CT#Chronic Calculous and Acalculous Cholecystitis|CT abdomen]]<br>[[Cholecystitis other diagnostic studies#Chronic Cholecystitis|HIDA scan]]<br>[[Cholecystitis other diagnostic studies#Chronic Cholecystitis|Cholecystokinin stimulated HIDA scan]]</div>}} | ||
{{familytree | | | | | | | | | |!| | | |!| | | |!| |!| |!| | | | | | | | | | |}} | {{familytree | | | | | | | | | |!| | | |!| | | |!| |!| |!| | | | | | | | | | |}} | ||
{{familytree | | | | | | | | | C01 |-| C02 | | C03 |'| C04 | | | | | | | | | | | | |C01=<div style="float: left; text-align: left; line-height: 150% ">'''Examine the patient:'''<BR>❑ Febrile<BR>❑ Tachycardia<BR>❑ Dehydrated<BR>❑ Abdominal guarding<BR>❑ [[Murphy's sign]]<BR>❑ Abdominal crepitations<BR>❑ Abdominal tenderness<BR>❑ Reduced bowel sounds<BR>❑ Increased bowel sounds<BR>❑ Abdominal distension<BR>❑ [[Sepsis physical examination|Signs of sepsis]]</div>|C02=Consider DDx of '''acute acalculous cholecystitis'''|C03=Consider DDx of '''chronic cholecystitis'''|C04=<div style="float: left; text-align: left; line-height: 150% ">'''Uncomplicated chronic cholecystitis:'''<br> | {{familytree | | | | | | | | | C01 |-| C02 | | C03 |'| C04 | | | | | | | | | | | | |C01=<div style="float: left; text-align: left; line-height: 150% ">'''Examine the patient:'''<BR>❑ Febrile<BR>❑ Tachycardia<BR>❑ Dehydrated<BR>❑ Abdominal guarding<BR>❑ [[Murphy's sign]]<BR>❑ Abdominal crepitations<BR>❑ Abdominal tenderness<BR>❑ Reduced bowel sounds<BR>❑ Increased bowel sounds<BR>❑ Abdominal distension<BR>❑ [[Sepsis physical examination|Signs of sepsis]]</div>|C02=Consider DDx of '''acute acalculous cholecystitis'''|C03=Consider DDx of '''chronic cholecystitis'''|C04=<div style="float: left; text-align: left; line-height: 150% ">'''Uncomplicated chronic cholecystitis:'''<br> | ||
Line 54: | Line 54: | ||
Appropriate management of complications like acute on chronic cholecystitis or GB CA or gallstone ileus</div>}} | Appropriate management of complications like acute on chronic cholecystitis or GB CA or gallstone ileus</div>}} | ||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | |}} | {{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | |}} | ||
{{familytree | | | | | | | | | D01 |,| D02 |-| D03 |-|-|-|-|-|-|.| | | | | | | | | | |D01=<div style="float: left; text-align: left; line-height: 150% ">'''Order laboratory tests:'''<br>❑ CBC<br>❑ BMP<br>❑ Total bilirubin<br>❑ Direct bilirubin<br>❑ Albumin<br>❑ AST<br>❑ ALT<br>❑ Alkaline phosphatase<br>❑ GGT<br>❑ Amylase<br>❑ Lipase</div>|D02=No GBS/GB edema|D03=Consider evaluation for alternate diagnosis of abdominal pain}} | {{familytree | | | | | | | | | D01 |,| D02 |-| D03 |-|-|-|-|-|-|.| | | | | | | | | | |D01=<div style="float: left; text-align: left; line-height: 150% ">'''Order laboratory tests:'''<br>❑ CBC<br>❑ BMP<br>❑ Total bilirubin<br>❑ Direct bilirubin<br>❑ Albumin<br>❑ AST<br>❑ ALT<br>❑ Alkaline phosphatase<br>❑ GGT<br>❑ Amylase<br>❑ Lipase</div>|D02=No GBS/GB edema|D03=[[Abdominal pain resident survival guide|Consider evaluation for alternate diagnosis of abdominal pain]]}} | ||
{{familytree | | | | | | | | | |!| |!| | | | | | | | | | | | | |!| | | | | | |}} | {{familytree | | | | | | | | | |!| |!| | | | | | | | | | | | | |!| | | | | | |}} | ||
{{familytree | | | | | | | | | F01 |+| F02 |-| F03 |-| F04 | | |!| | | | | | | | | | | |F01='''Order urgent transabdominal USG (TAUSG)'''|F02=GBS w/o GB edema/GB edema w/o GBS|F03=HIDA scan|F04=GB opacity visualized}} | {{familytree | | | | | | | | | F01 |+| F02 |-| F03 |-| F04 | | |!| | | | | | | | | | | |F01='''Order urgent transabdominal USG (TAUSG)'''|F02=GBS w/o GB edema/GB edema w/o GBS|F03=HIDA scan|F04=GB opacity visualized}} | ||
Line 61: | Line 61: | ||
{{familytree | | | | | | | | | | | | | |!| | | |!| | | |!| | | |!| | | | | |}} | {{familytree | | | | | | | | | | | | | |!| | | |!| | | |!| | | |!| | | | | |}} | ||
{{familytree | | | | | | | | | H01 |-|-|^|-|-|-|'| | | H02 | | |!| | | | | | | | |H01=<div style="float: left; text-align: left; line-height: 150% ">'''Diagnostic criteria:'''<ref name="Takada-2007">{{Cite journal | last1 = Takada | first1 = T. | last2 = Kawarada | first2 = Y. | last3 = Nimura | first3 = Y. | last4 = Yoshida | first4 = M. | last5 = Mayumi | first5 = T. | last6 = Sekimoto | first6 = M. | last7 = Miura | first7 = F. | last8 = Wada | first8 = K. | last9 = Hirota | first9 = M. | title = Background: Tokyo Guidelines for the management of acute cholangitis and cholecystitis. | journal = J Hepatobiliary Pancreat Surg | volume = 14 | issue = 1 | pages = 1-10 | month = | year = 2007 | doi = 10.1007/s00534-006-1150-0 | PMID = 17252291 }}</ref><ref name="Hirota-2007">{{Cite journal | last1 = Hirota | first1 = M. | last2 = Takada | first2 = T. | last3 = Kawarada | first3 = Y. | last4 = Nimura | first4 = Y. | last5 = Miura | first5 = F. | last6 = Hirata | first6 = K. | last7 = Mayumi | first7 = T. | last8 = Yoshida | first8 = M. | last9 = Strasberg | first9 = S. | title = Diagnostic criteria and severity assessment of acute cholecystitis: Tokyo Guidelines. | journal = J Hepatobiliary Pancreat Surg | volume = 14 | issue = 1 | pages = 78-82 | month = | year = 2007 | doi = 10.1007/s00534-006-1159-4 | PMID = 17252300 }}</ref><br>❑ Local symptoms & signs<div class="mw-collapsible-content"> <div class="mw-collapsible mw-collapsed"> | {{familytree | | | | | | | | | H01 |-|-|^|-|-|-|'| | | H02 | | |!| | | | | | | | |H01=<div style="float: left; text-align: left; line-height: 150% ">'''Diagnostic criteria:'''<ref name="Takada-2007">{{Cite journal | last1 = Takada | first1 = T. | last2 = Kawarada | first2 = Y. | last3 = Nimura | first3 = Y. | last4 = Yoshida | first4 = M. | last5 = Mayumi | first5 = T. | last6 = Sekimoto | first6 = M. | last7 = Miura | first7 = F. | last8 = Wada | first8 = K. | last9 = Hirota | first9 = M. | title = Background: Tokyo Guidelines for the management of acute cholangitis and cholecystitis. | journal = J Hepatobiliary Pancreat Surg | volume = 14 | issue = 1 | pages = 1-10 | month = | year = 2007 | doi = 10.1007/s00534-006-1150-0 | PMID = 17252291 }}</ref><ref name="Hirota-2007">{{Cite journal | last1 = Hirota | first1 = M. | last2 = Takada | first2 = T. | last3 = Kawarada | first3 = Y. | last4 = Nimura | first4 = Y. | last5 = Miura | first5 = F. | last6 = Hirata | first6 = K. | last7 = Mayumi | first7 = T. | last8 = Yoshida | first8 = M. | last9 = Strasberg | first9 = S. | title = Diagnostic criteria and severity assessment of acute cholecystitis: Tokyo Guidelines. | journal = J Hepatobiliary Pancreat Surg | volume = 14 | issue = 1 | pages = 78-82 | month = | year = 2007 | doi = 10.1007/s00534-006-1159-4 | PMID = 17252300 }}</ref><br>❑ Local symptoms & signs<div class="mw-collapsible-content"> <div class="mw-collapsible mw-collapsed"> | ||
:❑ Murphy’s sign | :❑ [[Murphy’s sign]] | ||
:❑ Pain or tenderness in RUQ | :❑ Pain or tenderness in RUQ | ||
:❑ Mass in RUQ</div></div><br>❑ Systemic signs<div class="mw-collapsible-content"> <div class="mw-collapsible mw-collapsed"> | :❑ Mass in RUQ</div></div><br>❑ Systemic signs<div class="mw-collapsible-content"> <div class="mw-collapsible mw-collapsed"> | ||
Line 67: | Line 67: | ||
:❑ Leukocytosis | :❑ Leukocytosis | ||
:❑ Elevated CRP</div></div><br>❑ Imaging findings<div class="mw-collapsible-content"> <div class="mw-collapsible mw-collapsed"> | :❑ Elevated CRP</div></div><br>❑ Imaging findings<div class="mw-collapsible-content"> <div class="mw-collapsible mw-collapsed"> | ||
:❑ TAUSG | :❑ [[Cholecystitis ultrasound#Calculous Cholecystitis|TAUSG]] | ||
:❑ HIDA scan | :❑ [[Cholecystitis other diagnostic studies#Calculous Cholecystitis|HIDA scan]] </div></div></div>|H02=<div style="float: left; text-align: left; line-height: 150% ">'''Diagnostic criteria:'''<ref name="Huffman-2010">{{Cite journal | last1 = Huffman | first1 = JL. | last2 = Schenker | first2 = S. | title = Acute acalculous cholecystitis: a review. | journal = Clin Gastroenterol Hepatol | volume = 8 | issue = 1 | pages = 15-22 | month = Jan | year = 2010 | doi = 10.1016/j.cgh.2009.08.034 | PMID = 19747982 }}</ref><BR>❑ Acute abdominal pain<BR>❑ Fever<BR>❑ Leukocytosis<BR>❑ Abnormal liver function tets<BR>❑ Imaging based criteria<div class="mw-collapsible-content"> <div class="mw-collapsible mw-collapsed"> | ||
:❑ [[Cholecystitis ultrasound#Imaging Criteria for Acalculous Cholecystitis|TAUSG based]] | :❑ [[Cholecystitis ultrasound#Imaging Criteria for Acalculous Cholecystitis|TAUSG based]] | ||
:❑ [[Cholecystitis other diagnostic studies#Imaging Criteria for Acalculous Cholecystitis|HIDA scan based]] | :❑ [[Cholecystitis other diagnostic studies#Imaging Criteria for Acalculous Cholecystitis|HIDA scan based]] | ||
:❑ [[Cholecystitis CT#Imaging Criteria for Acalculous Cholecystitis|CT based criteria]]</div></div></div>}} | :❑ [[Cholecystitis CT#Imaging Criteria for Acalculous Cholecystitis|CT based criteria]]</div></div></div>}} | ||
{{familytree | | | | | | | | | |)|-|-| I01 |-| I02 | | |!| | | |!| | | | | | | |I01=W/ significantly elevated total bilirubin, alkaline phosphatase, ALT, AST &/or GGT|I02=Consider evaluation for alternate diagnosis like choledocholithiasis & cholangitis}} | {{familytree | | | | | | | | | |)|-|-| I01 |-| I02 | | |!| | | |!| | | | | | | |I01=W/ significantly elevated total bilirubin, alkaline phosphatase, ALT, AST &/or GGT|I02=Consider evaluation for alternate diagnosis like [[choledocholithiasis]] & [[cholangitis]]}} | ||
{{familytree | | | | | | | | | J01 | | | | | | | | | | J02 | | |!| | | | | | | |J01='''Acute calculous cholecystitis'''<br>w/ or w/o complications|J02=Suspect '''acute acalculous cholecystitis'''}} | {{familytree | | | | | | | | | J01 | | | | | | | | | | J02 | | |!| | | | | | | |J01='''Acute calculous cholecystitis'''<br>w/ or w/o complications|J02=Suspect '''acute acalculous cholecystitis'''}} | ||
{{familytree | | | | | | | | | |!| | | | | | | | | | | |!| | | |!| | | | | |}} | {{familytree | | | | | | | | | |!| | | | | | | | | | | |!| | | |!| | | | | |}} | ||
Line 85: | Line 85: | ||
{{familytree | | | | | | | | | L01 | | L02 | | L03 | | L04 | | | | | | | | | | |L01=Grade 1 (Mild)|L02=Grade 2 (Moderate)|L03=Grade 3 (Severe)|L04=Patient improves}} | {{familytree | | | | | | | | | L01 | | L02 | | L03 | | L04 | | | | | | | | | | |L01=Grade 1 (Mild)|L02=Grade 2 (Moderate)|L03=Grade 3 (Severe)|L04=Patient improves}} | ||
{{familytree | | | | | | | | | |!| | | |!| | | |!| | | |!| | | | | | |}} | {{familytree | | | | | | | | | |!| | | |!| | | |!| | | |!| | | | | | |}} | ||
{{familytree | | | | | | | | | M01 | | M02 | | M03 | | M04 | | | | |M01= | {{familytree | | | | | | | | | M01 | | M02 | | M03 | | M04 | | | | |M01=Cholecystectomy within 72 hours|M02=<div style="float: left; text-align: left; line-height: 150% ">'''W/o complications & non high risk surgical candidates:'''<br>Immediate cholecystectomy + blood C&S ± bile C&S<br>'''W/o complications & high risk surgical candidates:'''<br>Immediate biliary drainage + blood C&S ± bile C&S<br>'''W/ complications:'''<br>Emergency cholecystectomy + blood C&S ± bile C&S ± appropriate surgeries for [[Gallstone ileus#Treatment|gallstone ileus]] & [[Mirizzi's syndrome surgery|Mirizzi syndrome]]</div>|M03=Emergency biliary drainage + blood C&S ± bile C&S|M04=Urgent cholecystectomy}} | ||
{{familytree | | | | | | | | | | | | | | | | | |!| | | | | | | | | | |}} | {{familytree | | | | | | | | | | | | | | | | | |!| | | | | | | | | | |}} | ||
{{familytree | | | | | | | | | | | | | | | | | N01 | | | | | | | | | | | |N01=Cholecystectomy after 3 months if GBS found during biliary drainage}} | {{familytree | | | | | | | | | | | | | | | | | N01 | | | | | | | | | | | |N01=Cholecystectomy after 3 months if GBS found during biliary drainage}} | ||
{{familytree/end}} | {{familytree/end}} | ||
<sup>†</sup>ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; BMP: Basic Metabolic Profile; C&S: Culture & Sensitivity; CA: Carcinoma; CBC: Complete Blood Count; CT: Computed Tomography; DDx: Differential Diagnosis; GB: Gallbladder; GBS: Gallbladder stone; GGT: Gamma-glutamyl transpeptidase; HIDA scan: Hepatobiliary Iminodiacetic Acid scan; IV: Intravenous; IVF: Intravenous fluids; NPO: Nil Per Oral; RUQ: Right Upper Quadrant; Sx: Symptom; W/: With; W/O: Without | |||
==Do's== | ==Do's== | ||
*Antibiotics should be administered if infection is suspected on the basis of laboratory and clinical findings (>12,500 white cells/mm <sup>3</sup> or temperature >38.5°C) and radiographic findings (e.g., air in the gallbladder or gallbladder wall) as per the Infectious Diseases Society of America recommendation.<ref name="Solomkin-2003">{{Cite journal | last1 = Solomkin | first1 = JS. | last2 = Mazuski | first2 = JE. | last3 = Baron | first3 = EJ. | last4 = Sawyer | first4 = RG. | last5 = Nathens | first5 = AB. | last6 = DiPiro | first6 = JT. | last7 = Buchman | first7 = T. | last8 = Dellinger | first8 = EP. | last9 = Jernigan | first9 = J. | title = Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. | journal = Clin Infect Dis | volume = 37 | issue = 8 | pages = 997-1005 | month = Oct | year = 2003 | doi = 10.1086/378702 | PMID = 14523762 }}</ref> | |||
*Prophylactic antibiotics before surgery | |||
**Should be administered in highrisk patients (age >60 years, presence of [[diabetes]], acute colic within 30 days of operation, [[jaundice]], [[acute cholecystitis]], or [[cholangitis]]). (Level I, Grade B) | |||
**Should be limited to a single preoperative dose given within 1 hour of skin incision. (Level II, Grade A) | |||
*Early [[laparoscopic cholecystectomy]] is the preferred approach and should be done in patients with acute cholecystitis. (Level II, Grade B) | |||
*Radiographically guided percutaneous cholecystostomy is the effective method of biliary drainage and should be done in critically ill patients with acute cholecystitis, until the patient recovers sufficiently to undergo cholecystectomy. (Level II, Grade B) | |||
*Time to discharge after surgery for patients with acute cholecystitis should be determined on an individual basis. (Level III, Grade A) | |||
==Dont's== | ==Dont's== | ||
*Antibiotics are not required in low-risk patients undergoing laparoscopic cholecystectomy. (Level I, Grade A) | |||
*Drains are not required after elective laparoscopic cholecystectomy, and their use may increase complication rates. (Level I, Grade A) | |||
==References== | ==References== |
Revision as of 19:23, 9 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vendhan Ramanujam M.B.B.S [2]
Cholecystitis
Definitions
Terms | Definitions |
---|---|
Cholecystitis | Cholecystitis is an inflammatory disease of the gallbladder. |
Acute cholecystitis | Acute cholecystitis is an acute inflammatory disease of the gallbladder, most often attributable to gallstones.[1][2] |
Acute calculous cholecystitis | Acute calculous cholecystitis is an acute inflammatory disease of the gallbladder in the presence of cholelithiasis.[1] The Tokyo guidelines is used in the diagnosis of acute calculous cholecystitis.[3][4] |
Acute acalculous cholecystitis | Acute acalculous cholecystitis is an acute necroinflammatory disease of the gallbladder in the absence of cholelithiasis and has a multifactorial pathogenesis.[5] Data from multiple studies is used for suspecting the diagnosis of acute acalculous cholecystitis.[5] |
Chronic cholecystitis | Chronic cholecystitis is a chronic inflammatory disease of the gallbladder with histological evidence of chronic inflammation like large range of related inflammatory epithelial changes including mononuclear infiltrate, fibrosis, thickening of muscular layer, dysplasia, hyperplasia and metaplasia.[6] |
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Common Causes
Management
Shown below is a diagram depicting the management of cholecystitis according to the Society for Surgery of the Alimentary Tract (SSAT),[8] the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES),[9] Tokyo guidelines for management of cholecystitis,[10] and review of data from multiple studies on acalculous cholecystitis.[5]
Characterize the symptoms ❑ Abdominal pain | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
❑ Acute RUQ or epigastric pain ❑ Sharp, severe and steady pain ❑ Pain associated with Sx suggestive of Mirizzi syndrome
❑ Pain associated with Sx suggestive of gallstone ileus | ❑ Acute vague abdominal pain ❑ RUQ mass ❑ Jaundice ❑ Fever | ❑ Recurrent biliary type abdominal pain ❑ Recurrent abdominal bloating ❑ Unstable stool with constipation/diarrhea ❑ Weight loss | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Examine the patient: ❑ Febrile ❑ Tachycardia ❑ Dehydrated ❑ Abdominal guarding ❑ Murphy's sign ❑ Abdominal crepitations ❑ Abdominal tenderness ❑ Reduced bowel sounds ❑ Increased bowel sounds ❑ Abdominal distension ❑ Signs of sepsis | Consider DDx of acute acalculous cholecystitis | Consider DDx of chronic cholecystitis | Uncomplicated chronic cholecystitis: Elective cholecystectomy | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Order laboratory tests: ❑ CBC ❑ BMP ❑ Total bilirubin ❑ Direct bilirubin ❑ Albumin ❑ AST ❑ ALT ❑ Alkaline phosphatase ❑ GGT ❑ Amylase ❑ Lipase | No GBS/GB edema | Consider evaluation for alternate diagnosis of abdominal pain | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Order urgent transabdominal USG (TAUSG) | GBS w/o GB edema/GB edema w/o GBS | HIDA scan | GB opacity visualized | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GBS w/ GB edema | GB opacity not visualized | CT abdomen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Diagnostic criteria:[3][4] ❑ Local symptoms & signs
❑ Systemic signs ❑ Imaging findings | Diagnostic criteria:[5] ❑ Acute abdominal pain ❑ Fever ❑ Leukocytosis ❑ Abnormal liver function tets ❑ Imaging based criteria | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
W/ significantly elevated total bilirubin, alkaline phosphatase, ALT, AST &/or GGT | Consider evaluation for alternate diagnosis like choledocholithiasis & cholangitis | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Acute calculous cholecystitis w/ or w/o complications | Suspect acute acalculous cholecystitis | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
❑ Hospital admission ❑ NPO ❑ IVF & correct electrolyte abnormalities ❑ Empiric IV antibiotics[11]
or
❑ Acute pain management | Immediate biliary drainage | Patient does not improve | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Grade 1 (Mild) | Grade 2 (Moderate) | Grade 3 (Severe) | Patient improves | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cholecystectomy within 72 hours | W/o complications & non high risk surgical candidates: Immediate cholecystectomy + blood C&S ± bile C&S W/o complications & high risk surgical candidates: Immediate biliary drainage + blood C&S ± bile C&S W/ complications: Emergency cholecystectomy + blood C&S ± bile C&S ± appropriate surgeries for gallstone ileus & Mirizzi syndrome | Emergency biliary drainage + blood C&S ± bile C&S | Urgent cholecystectomy | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cholecystectomy after 3 months if GBS found during biliary drainage | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
†ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; BMP: Basic Metabolic Profile; C&S: Culture & Sensitivity; CA: Carcinoma; CBC: Complete Blood Count; CT: Computed Tomography; DDx: Differential Diagnosis; GB: Gallbladder; GBS: Gallbladder stone; GGT: Gamma-glutamyl transpeptidase; HIDA scan: Hepatobiliary Iminodiacetic Acid scan; IV: Intravenous; IVF: Intravenous fluids; NPO: Nil Per Oral; RUQ: Right Upper Quadrant; Sx: Symptom; W/: With; W/O: Without
Do's
- Antibiotics should be administered if infection is suspected on the basis of laboratory and clinical findings (>12,500 white cells/mm 3 or temperature >38.5°C) and radiographic findings (e.g., air in the gallbladder or gallbladder wall) as per the Infectious Diseases Society of America recommendation.[11]
- Prophylactic antibiotics before surgery
- Should be administered in highrisk patients (age >60 years, presence of diabetes, acute colic within 30 days of operation, jaundice, acute cholecystitis, or cholangitis). (Level I, Grade B)
- Should be limited to a single preoperative dose given within 1 hour of skin incision. (Level II, Grade A)
- Early laparoscopic cholecystectomy is the preferred approach and should be done in patients with acute cholecystitis. (Level II, Grade B)
- Radiographically guided percutaneous cholecystostomy is the effective method of biliary drainage and should be done in critically ill patients with acute cholecystitis, until the patient recovers sufficiently to undergo cholecystectomy. (Level II, Grade B)
- Time to discharge after surgery for patients with acute cholecystitis should be determined on an individual basis. (Level III, Grade A)
Dont's
- Antibiotics are not required in low-risk patients undergoing laparoscopic cholecystectomy. (Level I, Grade A)
- Drains are not required after elective laparoscopic cholecystectomy, and their use may increase complication rates. (Level I, Grade A)
References
- ↑ 1.0 1.1 Strasberg, SM. (2008). "Clinical practice. Acute calculous cholecystitis". N Engl J Med. 358 (26): 2804–11. doi:10.1056/NEJMcp0800929. PMID 18579815. Unknown parameter
|month=
ignored (help) - ↑ Reiss, R.; Deutsch, AA. (1993). "State of the art in the diagnosis and management of acute cholecystitis". Dig Dis. 11 (1): 55–64. PMID 8443956.
- ↑ 3.0 3.1 Takada, T.; Kawarada, Y.; Nimura, Y.; Yoshida, M.; Mayumi, T.; Sekimoto, M.; Miura, F.; Wada, K.; Hirota, M. (2007). "Background: Tokyo Guidelines for the management of acute cholangitis and cholecystitis". J Hepatobiliary Pancreat Surg. 14 (1): 1–10. doi:10.1007/s00534-006-1150-0. PMID 17252291.
- ↑ 4.0 4.1 4.2 Hirota, M.; Takada, T.; Kawarada, Y.; Nimura, Y.; Miura, F.; Hirata, K.; Mayumi, T.; Yoshida, M.; Strasberg, S. (2007). "Diagnostic criteria and severity assessment of acute cholecystitis: Tokyo Guidelines". J Hepatobiliary Pancreat Surg. 14 (1): 78–82. doi:10.1007/s00534-006-1159-4. PMID 17252300.
- ↑ 5.0 5.1 5.2 5.3 Huffman, JL.; Schenker, S. (2010). "Acute acalculous cholecystitis: a review". Clin Gastroenterol Hepatol. 8 (1): 15–22. doi:10.1016/j.cgh.2009.08.034. PMID 19747982. Unknown parameter
|month=
ignored (help) - ↑ Zhou, D.; Guan, WB.; Wang, JD.; Zhang, Y.; Gong, W.; Quan, ZW. (2013). "A comparative study of clinicopathological features between chronic cholecystitis patients with and without Helicobacter pylori infection in gallbladder mucosa". PLoS One. 8 (7): e70265. doi:10.1371/journal.pone.0070265. PMID 23936177.
- ↑ Kimura, Y.; Takada, T.; Kawarada, Y.; Nimura, Y.; Hirata, K.; Sekimoto, M.; Yoshida, M.; Mayumi, T.; Wada, K. (2007). "Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo Guidelines". J Hepatobiliary Pancreat Surg. 14 (1): 15–26. doi:10.1007/s00534-006-1152-y. PMID 17252293.
- ↑ Duncan, CB.; Riall, TS. (2012). "Evidence-based current surgical practice: calculous gallbladder disease". J Gastrointest Surg. 16 (11): 2011–25. doi:10.1007/s11605-012-2024-1. PMID 22986769. Unknown parameter
|month=
ignored (help) - ↑ Overby, DW.; Apelgren, KN.; Richardson, W.; Fanelli, R.; Overby, DW.; Apelgren, KN.; Beghoff, KR.; Curcillo, P.; Awad, Z. (2010). "SAGES guidelines for the clinical application of laparoscopic biliary tract surgery". Surg Endosc. 24 (10): 2368–86. doi:10.1007/s00464-010-1268-7. PMID 20706739. Unknown parameter
|month=
ignored (help) - ↑ Mayumi, T.; Someya, K.; Ootubo, H.; Takama, T.; Kido, T.; Kamezaki, F.; Yoshida, M.; Takada, T. (2013). "Progression of Tokyo Guidelines and Japanese Guidelines for management of acute cholangitis and cholecystitis". J UOEH. 35 (4): 249–57. PMID 24334691. Unknown parameter
|month=
ignored (help) - ↑ 11.0 11.1 Solomkin, JS.; Mazuski, JE.; Baron, EJ.; Sawyer, RG.; Nathens, AB.; DiPiro, JT.; Buchman, T.; Dellinger, EP.; Jernigan, J. (2003). "Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections". Clin Infect Dis. 37 (8): 997–1005. doi:10.1086/378702. PMID 14523762. Unknown parameter
|month=
ignored (help)